A phase II study of cabozantinib and temozolomide in advanced progressive gastroenteropancreatic or lung neuroendocrine tumors (NETs)

被引：0

作者：

Clemente, O. ^{[1
]}

Cives, M. ^{[2
]}

Guerrera, L. P. ^{[1
]}

Tornesello, M. L. ^{[3
]}

Bracigliano, A. ^{[4
]}

Lauricella, E. ^{[5
]}

Ragno, A. ^{[2
]}

Scarpati, G. Della Vittoria ^{[1
]}

Starita, N. ^{[3
]}

Picozzi, F. ^{[1
]}

Barretta, M. L. ^{[6
]}

Badalamenti, G. ^{[2
,7
]}

Cannella, L. ^{[1
]}

Lastoria, S. ^{[4
]}

Di Mauro, A. ^{[8
]}

Porta, C. G. ^{[2
]}

Tafuto, S. ^{[1
]}

机构：

[1] Ist Nazl Tumori IRCCS Fdn G Pascale, Rare Tumors & Sarcomas Dept, Naples, Italy

[2] Azienda Osped Univ Consorziale Policlin Bari, Med Oncol Unit, Bari, Italy

[3] Ist Nazl Tumori IRCCS Fdn G Pascale, Unit Mol Biol & Viral Oncogenesis, Naples, Italy

[4] Ist Nazl Tumori IRCCS Fdn G Pascale, Nucl Med Unit, Naples, Italy

[5] Univ Bari Aldo Moro, Interdisciplinary Dept Med, Bari, Italy

[6] Ist Nazl Tumori IRCCS Fdn G Pascale, Dept Radiol, Naples, Italy

[7] AOU Policlin Paolo Giaccone, Dept Oncol, Palermo, Italy

[8] Ist Nazl Tumori IRCCS Fdn G Pascale, Unit Patol, Naples, Italy

来源：

ANNALS OF ONCOLOGY | 2024年 / 35卷

关键词：

D O I：

10.1016/j.annonc.2024.05.220

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

212P

引用

页码：S93 / S93

页数：1

共 50 条

[21] Phase II Trial of Cabozantinib in Patients With Carcinoid and Pancreatic Neuroendocrine Tumors
Chan, Jennifer
Faris, Jason
Murphy, Janet
Blaszkowsky, Lawrence
Kwak, Eunice
McCleary, Nadine
Fuchs, Charles
Meyerhardt, Jeffrey
Ng, Kimmie
Zhu, Andrew
Abrams, Thomas
Wolpin, Brian
Zhang, Sui
Reardon, Amanda
Fitzpatrick, Bridget
Kulke, Matthew
Ryan, David
PANCREAS, 2018, 47 (03) : 334 - 334
[22] Experience of Temozolomide Mono- and Combination Therapy in Advanced Neuroendocrine Tumors (NETs) in Russia
Gorbunova, V
Markovich, A.
Orel, N.
Kuzminov, A.
Odintsova, A.
Polozkova, S.
Mnatsakanyan, A.
NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 266 - 266
[23] Phase II study of pemetrexed in patients with advanced neuroendocrine tumors
Jennifer A. Chan
Andrew X. Zhu
Keith Stuart
Pankaj Bhargava
Craig C. Earle
Jeffrey W. Clark
Carolyn Casey
Eileen Regan
Matthew H. Kulke
Cancer Chemotherapy and Pharmacology, 2010, 66 : 961 - 968
[24] Phase II study of pemetrexed in patients with advanced neuroendocrine tumors
Chan, Jennifer A.
Zhu, Andrew X.
Stuart, Keith
Bhargava, Pankaj
Earle, Craig C.
Clark, Jeffrey W.
Casey, Carolyn
Regan, Eileen
Kulke, Matthew H.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 961 - 968
[25] Differential prognosis according to metastatic patterns in advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
Rosas, V.
Rosales Sotomayor, A.
Hernandez Martinez, A.
Gamboa Dominguez, A.
Noguez Ramos, A.
Huitzil Melendez, F. D.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : S416 - S417
[26] Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors
Patel, Dainik
Chan, David
Cehic, Gabrielle
Pavlakis, Nick
Price, Timothy Jay
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (04) : 311 - 327
[27] Emerging Therapies for Advanced Gastroenteropancreatic Neuroendocrine Tumors
Gupta, Sameer
Engstrom, Paul F.
Cohen, Steven J.
CLINICAL COLORECTAL CANCER, 2011, 10 (04) : 298 - 309
[28] Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)
Dhingra, Rohit
Tse, Julie Y.
Saif, Muhammad Wasif
JOURNAL OF THE PANCREAS, 2018, 19 (05): : 258 - 260
[29] Predictive Markers of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETS)
Issaeva, S.
Khalimova, Z.
Safarova, M.
Gumarova, A.
Yuldashev, A.
NEUROENDOCRINOLOGY, 2018, 106 : 89 - 89
[30] Anticancer activity of Cabozantinib and Temozolomide in cell lines derived from lung carcinoid and pancreatic neuroendocrine tumors
Tornesello, M. L.
Starita, N.
Clemente, O.
Cerasuolo, A.
Bracigliano, A.
Amiranda, S.
Picozzi, F.
Cannella, L.
Guerrera, L. P.
Pizzolorusso, A.
Tafuto, S.
JOURNAL OF NEUROENDOCRINOLOGY, 2024, 36 : 54 - 54

← 1 2 3 4 5 →